Company Filing History:
Years Active: 2020
Title: The Innovations of Thomas Floss
Introduction
Thomas Floss is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical science, particularly in the area of fatty acid applications for therapeutic treatments. His work focuses on addressing impaired sphingolipid metabolism, which is crucial for various bodily functions.
Latest Patents
Thomas Floss holds a patent for the application of omega-3 and/or omega-6 fatty acids in the therapeutic treatment of the human or animal body in cases of impaired sphingolipid metabolism. This patent specifically addresses conditions related to the defective formation of sphingomyelin synthase enzymes, which are vital for sphingolipid synthesis. The patent highlights the use of polyunsaturated omega-3 and/or omega-6 fatty acids, including EPA, DHA, DPA, ETA, 21:5n3, and SDA, in treating these metabolic issues.
Career Highlights
Floss is associated with K.D. Pharma Bexbach GmbH, where he continues to innovate and develop solutions for complex health issues. His research has proven beneficial in cases involving defects in the sphingomyelin synthase 1 and 2 genes, showcasing his commitment to advancing medical treatments.
Collaborations
Throughout his career, Thomas Floss has collaborated with esteemed colleagues such as Tobias Hartmann and Marcus Otto Walter Grimm. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field.
Conclusion
Thomas Floss is a pioneering inventor whose work in omega-3 and omega-6 fatty acids has the potential to transform therapeutic approaches for impaired sphingolipid metabolism. His contributions to medical science are invaluable and continue to inspire future innovations.